MEAGHAN BROWN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care HOUSTON, TX NPI 1699250787
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care TX NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$2,521.09
- Category: General Payments
- Program years: PY2021–2024
- Record count: 106
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,088.43 across 44 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $913.45 | 42 |
| Education | $174.98 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $152.45 | 7 |
| Merck Sharp & Dohme Corporation | $100.90 | 4 |
| Acerta Pharma LLC | $100.80 | 5 |
| SEAGEN INC. | $99.99 | 1 |
| Lilly USA, LLC | $83.40 | 3 |
| Astellas Pharma US Inc | $74.99 | 1 |
| PharmaEssentia USA Corporation | $65.06 | 3 |
| ABBVIE INC. | $54.70 | 3 |
| EISAI INC. | $45.57 | 2 |
| E.R. Squibb & Sons, L.L.C. | $44.88 | 2 |
| Rigel Pharmaceuticals, Inc. | $26.18 | 1 |
| Incyte Corporation | $24.56 | 1 |
| GlaxoSmithKline, LLC. | $24.42 | 1 |
| Blueprint Medicines Corporation | $21.66 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.45 | 1 |
| Daiichi Sankyo Inc. | $21.16 | 1 |
| Janssen Biotech, Inc. | $20.94 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $19.75 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.11 | 1 |
| SERVIER PHARMACEUTICALS LLC | $18.08 | 1 |
| Ipsen Biopharmaceuticals, Inc | $17.32 | 1 |
| PFIZER INC. | $16.00 | 1 |
| Exelixis Inc. | $15.06 | 1 |
By program year
Records — PY2024 (44)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.